[1]
A. . Pandey, “HBV Pre-S Mutants and Hepatocellular Carcinoma: New Molecular Pathways, Clinical Implications, and Therapeutic Horizons (2020–2025)”, JEPMR, vol. 1, no. 2, pp. 87–126, Aug. 2025, Accessed: Aug. 29, 2025. [Online]. Available: https://jepmr.nknpub.com/1/article/view/9